BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  NeuroRx Signs Agreement With U.S. Dept. of Veterans Affairs and Baylor College of Medicine for Clinical Trial of First Drug Regimen Targeting Severe Bipolar Depression in Patients With Acute Suicidal Ideation & Behavior (ASIB)

  The collaboration also includes Baylor College of Medicine, in Houston, TX.

  December 27, 2017

   · 

  5 min read
• BioMidwest

  Cincinnati Children’s Hospital Medical Center Study Explores Impact of Obesity on Bone Marrow Cells

  New research published in the Journal of Experimental Medicine highlights the pernicious effect of obesity on the long-term health of blood-making stem cells.

  December 27, 2017

   · 

  2 min read
• Drug Development

  BiondVax Plans Phase III Clinical Trial Following Receipt of Scientific Advice From the EMA

  BiondVax announced today that the EMA’s CHMP reviewed BiondVax’s Phase 3 trial plan, provided advice, and allowed the Company to proceed with the Phase 3 clinical trial plan for M-001, BiondVax’s universal flu vaccine candidate.

  December 27, 2017

   · 

  4 min read
• BioMidwest

  Cellular Dynamics International Sends Human iPSC-Derived Cardiomyocytes To International Space Station On NASA Resupply Mission

  The purpose of the scientific research project utilizing CDI’s iCell Cardiomyocytes in space is to validate the function of NASA’s new Bioculture System for automated cell culture on the International Space Station and to study human cardiac cell function in microgravity.

  December 27, 2017

   · 

  3 min read
• Teva Announces Exclusive Launch of a Generic Version of Reyataz in the United States

  Atazanavir sulfate capsules are a protease inhibitor indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection for patients 6 years and older weighing at least 15 kg.

  December 27, 2017

   · 

  9 min read
• Pharm Country

  Up to 10 Percent Off for 2017 Christmas and the New Year From Creative BioMart

  Creative BioMart recently launched its biggest promotion of the year 2017 to celebrate the coming Christmas and the New Year.

  December 27, 2017

   · 

  1 min read
• Business

  Keryx Biopharma and Siegfried Enter Into a Master Manufacturing Services and Supply Agreement

  The Agreement has an initial term ending on December 31, 2021 and will automatically renew after that for successive terms of one year each.

  December 27, 2017

   · 

  1 min read
• BioMidwest

  Medizone International Attending the J.P. Morgan 36th Annual Healthcare Conference for Partnership and Investment Discussions

  Medizone announced today the Company’s management will be attending the J.P. Morgan 36th Annual Healthcare Conference in San Francisco, January 8th through 11th.

  December 27, 2017

   · 

  2 min read
• Policy

  Merus Announces the U.S. Court of Appeals for the Federal Circuit Denies Regeneron’s Petition to Rehear the Panel’s Decision Affirming Merus’ Inequitable Conduct Claim Against Regeneron

  Regeneron filed the complaint against Merus alleging that it infringed one or more claims in the ‘018 patent in 2014.

  December 27, 2017

   · 

  6 min read
• Policy

  Protalix BioTherapeutics’ PRX-102 Granted Orphan Drug Designation by the European Commission

  The decision by the Commission confirms the opinion previously issued by the EMA Committee for Orphan Medicinal Products.

  December 27, 2017

   · 

  4 min read